In the cerebrospinal fluid (CSF) of patients with MS, there is an elevated expression of IL-1β, IL-1 receptor accessory protein, and IL-1 receptor antagonist (IL-1Ra). This evidence concerns the gene IL1B and myeloid sarcoma.